Chinese experts have developed a medicine to treat corona
May 22 2020
Researchers at Peking University claim they have developed a drug that can bring COVID-19 to a halt. The drug is now tested in Peking University in China by scientists and they believe that it could shorten the recovery time for all those who are infected with coronavirus. The drug has passed the animal testing stage with flying colours, Sunney Xie, Director of the university's Beijing Advanced Innovation Center for Genomics, told AFP. The neutralizing antibodies that the researchers injected into the mice cut the viral load by a factor of 2,500. The team's research was published in the journal Cell. This showed that the potential drug had a therapeutic effect.
Dr Xie said his team's "expertise is in single-cell genomics rather than immunology or virology".
Xie believes it could take about six months before the drug is ready for use.
Xie added that preparation for a clinical trial is well underway, revealing that it will be conducted in Australia.
The researchers hope that these antibodies can be used to develop a drug that will fight off existing coronavirus infections while the world patiently waits for a vaccine to be developed, tested, and distributed.
Every year on June 4 in Hong Kong, tens of thousands join a candlelight vigil in the biggest commemoration of the 1989 crackdown in which Chinese troops opened fire on student-led democracy protesters in and around Beijing's Tiananmen Square.
But the new drug, developed in China, also provides protection from the virus for some time, meaning that people will not be able to get the disease for some time.
The plasma therapy has shown potential benefits in many countries, including India and China.
This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".
Drugs based on the use of antibodies have previously been successful in treating viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).
Xi said that he and his team are working day and night in search of antibodies.
"According to the plan, if all goes well, the above projects will complete the second phase of clinical trials in July this year."
It's now being tested at Peking University, and if it proves to be safe and effective we may not have to wait for a vaccine in order to feel a bit safer in the midst of the pandemic.
The novel coronavirus first emerged in Wuhan in late 2019, prompting the Chinese government to impose a stringent lockdown in the city on January 23, isolating the industrial and transport centre from the rest of the country and confining residents to their homes. The last time the commission reported a death was on 14 April.